Clinical Trial Update: A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161 [Phase 1]

View source ↗

Summary

This Phase 1 trial assesses the relative bioavailability of a new formulation of BCX4161 and the effect of food on its absorption in hereditary angioedema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• BCX4161

Snippet

Sponsor: BioCryst Pharmaceuticals | Conditions: Hereditary Angioedema | Phase 1 | Status: COMPLETED